SIMILAR PATTERNS OF AMINO ACIDS FOR 3KEE_B_30BB500_2

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ap2 MONOCLONAL ANTIBODY
C219

(Mus musculus) 		PF07686
(V-set) 		3 PHE A  77
TYR A  98
LEU A  53
 None
 0.70A 3keeB-1ap2A:
undetectable		 3keeB-1ap2A:
21.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1c4o DNA NUCLEOTIDE
EXCISION REPAIR
ENZYME UVRB

(Thermus
thermophilus) 		PF00271
(Helicase_C)
PF04851
(ResIII)
PF12344
(UvrB) 		3 PHE A  86
TYR A 143
LEU A  70
 None
 0.71A 3keeB-1c4oA:
0.0		 3keeB-1c4oA:
14.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1clw TAILSPIKE PROTEIN

(Salmonella
virus P22) 		PF09251
(PhageP22-tail) 		3 PHE A 381
TYR A 320
LEU A 432
 None
 0.80A 3keeB-1clwA:
0.0		 3keeB-1clwA:
16.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1cu1 PROTEIN
(PROTEASE/HELICASE
NS3)

(Hepacivirus C) 		PF02907
(Peptidase_S29)
PF07652
(Flavi_DEAD) 		3 PHE A  43
TYR A  56
LEU A 135
 None
 0.38A 3keeB-1cu1A:
32.3		 3keeB-1cu1A:
32.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1f6l ANTI-FERRITIN
IMMUNOGLOBULIN LIGHT
CHAIN

(Homo sapiens) 		PF07686
(V-set) 		3 PHE L  71
TYR L  92
LEU L  47
 None
 0.67A 3keeB-1f6lL:
undetectable		 3keeB-1f6lL:
23.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1i60 IOLI PROTEIN

(Bacillus
subtilis) 		PF01261
(AP_endonuc_2) 		3 PHE A 143
TYR A 158
LEU A 106
 None
 0.62A 3keeB-1i60A:
0.0		 3keeB-1i60A:
17.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1ns3 NS3 PROTEASE

(Hepacivirus C) 		PF02907
(Peptidase_S29) 		3 PHE A  43
TYR A  56
LEU A 135
 None
 0.45A 3keeB-1ns3A:
32.7		 3keeB-1ns3A:
96.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ofe FERREDOXIN-DEPENDENT
GLUTAMATE SYNTHASE 2

(Synechocystis
sp. PCC 6803) 		PF00310
(GATase_2)
PF01493
(GXGXG)
PF01645
(Glu_synthase)
PF04898
(Glu_syn_central) 		3 PHE A1316
TYR A1332
LEU A1284
 None
 0.70A 3keeB-1ofeA:
undetectable		 3keeB-1ofeA:
8.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qac IMMUNOGLOBULIN LIGHT
CHAIN VARIABLE
DOMAIN

(Homo sapiens) 		PF07686
(V-set) 		3 PHE A  71
TYR A  92
LEU A  47
 None
 0.75A 3keeB-1qacA:
undetectable		 3keeB-1qacA:
19.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1r75 HYPOTHETICAL PROTEIN

(Leishmania
major) 		PF09149
(DUF1935) 		3 PHE A  47
TYR A  27
LEU A 102
 None
 0.66A 3keeB-1r75A:
undetectable		 3keeB-1r75A:
20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1viw ALPHA-AMYLASE-INHIBI
TOR

(Phaseolus
vulgaris) 		PF00139
(Lectin_legB) 		3 PHE B 105
TYR B 186
LEU B  82
 None
 0.61A 3keeB-1viwB:
undetectable		 3keeB-1viwB:
19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xdp POLYPHOSPHATE KINASE

(Escherichia
coli) 		PF02503
(PP_kinase)
PF13089
(PP_kinase_N)
PF13090
(PP_kinase_C) 		3 PHE A 598
TYR A 515
LEU A 529
 None
 0.56A 3keeB-1xdpA:
undetectable		 3keeB-1xdpA:
12.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xv5 DNA
ALPHA-GLUCOSYLTRANSF
ERASE

(Escherichia
virus T4) 		PF11440
(AGT) 		3 PHE A1146
TYR A1112
LEU A1119
 None
 0.77A 3keeB-1xv5A:
undetectable		 3keeB-1xv5A:
17.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yq6 MINOR CAPSID PROTEIN

(Salmonella
virus PRD1) 		PF08949
(DUF1860) 		3 PHE A 318
TYR A 279
LEU A 274
 None
 0.78A 3keeB-1yq6A:
undetectable		 3keeB-1yq6A:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2a2f EXOCYST COMPLEX
COMPONENT SEC15

(Drosophila
melanogaster) 		PF04091
(Sec15) 		3 PHE X 288
TYR X 227
LEU X 280
 None
 0.68A 3keeB-2a2fX:
undetectable		 3keeB-2a2fX:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2csd TOPOISOMERASE V

(Methanopyrus
kandleri) 		PF13412
(HTH_24)
PF14520
(HHH_5) 		3 PHE A 374
TYR A 402
LEU A 353
 None
 0.80A 3keeB-2csdA:
undetectable		 3keeB-2csdA:
17.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cuh TENASCIN-X

(Homo sapiens) 		PF00041
(fn3) 		3 PHE A  23
TYR A  61
LEU A  96
 None
 0.72A 3keeB-2cuhA:
undetectable		 3keeB-2cuhA:
24.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cw7 ENDONUCLEASE
PI-PKOII

(Thermococcus
kodakarensis) 		PF14528
(LAGLIDADG_3)
PF14890
(Intein_splicing) 		3 PHE A 347
TYR A 284
LEU A 354
 None
 0.79A 3keeB-2cw7A:
undetectable		 3keeB-2cw7A:
16.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fge ZINC METALLOPROTEASE
(INSULINASE FAMILY)

(Arabidopsis
thaliana) 		PF00675
(Peptidase_M16)
PF05193
(Peptidase_M16_C)
PF08367
(M16C_assoc) 		3 PHE A 107
TYR A 119
LEU A 104
 None
 0.72A 3keeB-2fgeA:
undetectable		 3keeB-2fgeA:
10.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2j3t TRAFFICKING PROTEIN
PARTICLE COMPLEX
SUBUNIT 4

(Homo sapiens) 		PF04099
(Sybindin) 		3 PHE D 119
TYR D 147
LEU D 111
 None
 0.49A 3keeB-2j3tD:
undetectable		 3keeB-2j3tD:
23.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2j63 AP-ENDONUCLEASE

(Leishmania
major) 		PF03372
(Exo_endo_phos) 		3 PHE A 440
TYR A 392
LEU A 165
 None
 0.71A 3keeB-2j63A:
undetectable		 3keeB-2j63A:
17.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2oq2 PHOSPHOADENOSINE
PHOSPHOSULFATE
REDUCTASE

(Saccharomyces
cerevisiae) 		PF01507
(PAPS_reduct) 		3 PHE A 156
TYR A  68
LEU A  55
 None
 0.77A 3keeB-2oq2A:
undetectable		 3keeB-2oq2A:
19.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pq0 HYPOTHETICAL
CONSERVED PROTEIN
GK1056

(Geobacillus
kaustophilus) 		PF08282
(Hydrolase_3) 		3 PHE A 205
TYR A 249
LEU A  15
 None
 0.80A 3keeB-2pq0A:
undetectable		 3keeB-2pq0A:
21.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2q8n GLUCOSE-6-PHOSPHATE
ISOMERASE

(Thermotoga
maritima) 		PF00342
(PGI) 		3 PHE A 403
TYR A 396
LEU A 252
 None
 0.73A 3keeB-2q8nA:
undetectable		 3keeB-2q8nA:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vnu EXOSOME COMPLEX
EXONUCLEASE RRP44

(Saccharomyces
cerevisiae) 		PF00773
(RNB)
PF17215
(Rrp44_S1)
PF17216
(Rrp44_CSD1) 		3 PHE D 829
TYR D 820
LEU D 834
 None
None
A  B  -4 ( 4.4A)
 0.72A 3keeB-2vnuD:
undetectable		 3keeB-2vnuD:
12.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wp8 EXOSOME COMPLEX
EXONUCLEASE DIS3

(Saccharomyces
cerevisiae) 		PF00773
(RNB)
PF13638
(PIN_4)
PF17215
(Rrp44_S1)
PF17216
(Rrp44_CSD1) 		3 PHE J 829
TYR J 820
LEU J 834
 None
 0.75A 3keeB-2wp8J:
undetectable		 3keeB-2wp8J:
10.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2x2u PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE RECEPTOR RET

(Homo sapiens) 		PF00028
(Cadherin) 		3 PHE A 147
TYR A  36
LEU A 119
 None
 0.72A 3keeB-2x2uA:
undetectable		 3keeB-2x2uA:
21.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ycb CLEAVAGE AND
POLYADENYLATION
SPECIFICITY FACTOR

(Methanothermobacter
thermautotrophicus) 		PF07521
(RMMBL)
PF10996
(Beta-Casp)
PF16661
(Lactamase_B_6)
PF17214
(KH_7) 		3 PHE A 416
TYR A 535
LEU A 331
 None
 0.56A 3keeB-2ycbA:
undetectable		 3keeB-2ycbA:
13.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3auv SC-DSFV DERIVED FROM
THE G6-FAB

(Homo sapiens) 		PF07686
(V-set) 		3 PHE A  82
TYR A 103
LEU A  58
 None
 0.72A 3keeB-3auvA:
undetectable		 3keeB-3auvA:
21.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bd3 CATALYTIC ANTIBODY

(Mus musculus) 		PF07686
(V-set) 		3 PHE A 235
TYR A 256
LEU A 211
 None
 0.74A 3keeB-3bd3A:
undetectable		 3keeB-3bd3A:
20.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3djc TYPE III
PANTOTHENATE KINASE

(Legionella
pneumophila) 		PF03309
(Pan_kinase) 		3 PHE A 136
TYR A 235
LEU A 146
 None
 0.61A 3keeB-3djcA:
undetectable		 3keeB-3djcA:
24.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dur ANTIBODY FV FRAGMENT
SAG173-04

(Mus musculus) 		PF07686
(V-set) 		3 PHE A  71
TYR A  92
LEU A  47
 None
KDO  A 303 (-4.9A)
None
 0.72A 3keeB-3durA:
undetectable		 3keeB-3durA:
18.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3exn PROBABLE
ACETYLTRANSFERASE

(Thermus
thermophilus) 		PF00583
(Acetyltransf_1) 		3 PHE A  65
TYR A  73
LEU A   7
 None
None
CL  A 159 (-4.4A)
 0.77A 3keeB-3exnA:
undetectable		 3keeB-3exnA:
19.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3h9p PUTATIVE
TRIPHOSPHORIBOSYL-DE
PHOSPHO-COA SYNTHASE

(Archaeoglobus
fulgidus) 		PF01874
(CitG) 		3 PHE A 190
TYR A 206
LEU A 269
 None
 0.78A 3keeB-3h9pA:
undetectable		 3keeB-3h9pA:
18.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3iy0 FAB 14, LIGHT DOMAIN

(Mus musculus) 		PF07686
(V-set) 		3 PHE L  71
TYR L  92
LEU L  47
 None
 0.75A 3keeB-3iy0L:
undetectable		 3keeB-3iy0L:
18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3j4j TRANSLATION
INITIATION FACTOR
IF-2

(Thermus
thermophilus) 		PF00009
(GTP_EFTU)
PF04760
(IF2_N)
PF11987
(IF-2) 		3 PHE A 430
TYR A 456
LEU A 449
 None
 0.76A 3keeB-3j4jA:
undetectable		 3keeB-3j4jA:
15.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3j7e H16.V5 FAB LIGHT
CHAIN

(Mus musculus) 		no annotation 3 PHE L  77
TYR L  98
LEU L  53
 None
 0.79A 3keeB-3j7eL:
undetectable		 3keeB-3j7eL:
18.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3k5j SUPPRESSOR OF FUSED
FAMILY PROTEIN

(Neisseria
gonorrhoeae) 		PF05076
(SUFU) 		3 PHE A 116
TYR A  53
LEU A 120
 None
 0.78A 3keeB-3k5jA:
undetectable		 3keeB-3k5jA:
23.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3la4 UREASE

(Canavalia
ensiformis) 		PF00449
(Urease_alpha)
PF00547
(Urease_gamma)
PF00699
(Urease_beta)
PF01979
(Amidohydro_1) 		3 PHE A 671
TYR A 349
LEU A 299
 None
 0.69A 3keeB-3la4A:
undetectable		 3keeB-3la4A:
12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lp9 LS-24

(Lathyrus
sativus) 		PF00045
(Hemopexin) 		3 PHE A  82
TYR A  62
LEU A  85
 None
 0.80A 3keeB-3lp9A:
undetectable		 3keeB-3lp9A:
22.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mnz ANTI-HIV-1 ANTIBODY
13H11 LIGHT CHAIN

(Homo sapiens;
Mus musculus) 		PF07654
(C1-set)
PF07686
(V-set) 		3 PHE A  71
TYR A  92
LEU A  47
 None
 0.68A 3keeB-3mnzA:
undetectable		 3keeB-3mnzA:
20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ntc FAB LIGHT CHAIN

(Homo sapiens;
Mus musculus) 		PF07654
(C1-set)
PF07686
(V-set) 		3 PHE L  71
TYR L  92
LEU L  47
 None
 0.70A 3keeB-3ntcL:
undetectable		 3keeB-3ntcL:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o52 GDP-MANNOSE
PYROPHOSPHATASE NUDK

(Escherichia
coli) 		PF00293
(NUDIX) 		3 PHE A 160
TYR A 183
LEU A 156
 None
NA  A7113 (-3.9A)
None
 0.76A 3keeB-3o52A:
undetectable		 3keeB-3o52A:
19.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3oc7 ENOYL-COA HYDRATASE

(Mycobacterium
avium) 		PF00378
(ECH_1) 		3 PHE A 120
TYR A 167
LEU A 153
 None
 0.63A 3keeB-3oc7A:
undetectable		 3keeB-3oc7A:
22.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qyj ALR0039 PROTEIN

(Nostoc sp. PCC
7120) 		PF00561
(Abhydrolase_1) 		3 PHE A 271
TYR A  34
LEU A 237
 None
 0.73A 3keeB-3qyjA:
undetectable		 3keeB-3qyjA:
19.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rl3 METALLOPHOSPHOESTERA
SE MPPED2

(Rattus
norvegicus) 		PF00149
(Metallophos) 		3 PHE A 286
TYR A 267
LEU A  81
 None
 0.69A 3keeB-3rl3A:
undetectable		 3keeB-3rl3A:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3s88 16F6 - HEAVY CHAIN

(Mus musculus) 		PF07654
(C1-set)
PF07686
(V-set) 		3 PHE H  35
TYR H  59
LEU H  20
 None
 0.79A 3keeB-3s88H:
undetectable		 3keeB-3s88H:
22.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3td7 FAD-LINKED
SULFHYDRYL OXIDASE
R596

(Acanthamoeba
polyphaga
mimivirus) 		PF04777
(Evr1_Alr) 		3 PHE A 165
TYR A 172
LEU A 160
 None
 0.78A 3keeB-3td7A:
undetectable		 3keeB-3td7A:
21.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3thu MANDELATE RACEMASE /
MUCONATE LACTONIZING
ENZYME FAMILY
PROTEIN

(Sphingomonas
sp. SKA58) 		PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C) 		3 PHE A  18
TYR A 383
LEU A  21
 None
 0.80A 3keeB-3thuA:
undetectable		 3keeB-3thuA:
17.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bgo EFEM M75 PEPTIDASE

(Pseudomonas
syringae) 		PF09375
(Peptidase_M75) 		3 PHE A 164
TYR A  51
LEU A  39
 None
 0.79A 3keeB-4bgoA:
undetectable		 3keeB-4bgoA:
20.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4big UNCHARACTERIZED
LIPOPROTEIN
SAOUHSC_00053

(Staphylococcus
aureus) 		PF04507
(DUF576) 		3 PHE A 232
TYR A 186
LEU A 235
 None
 0.74A 3keeB-4bigA:
undetectable		 3keeB-4bigA:
20.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4f48 PUTATIVE
UNCHARACTERIZED
PROTEIN

(Xanthomonas
campestris) 		PF00563
(EAL) 		3 PHE A  42
TYR A  39
LEU A  45
 C2E  A 501 (-3.6A)
None
None
 0.70A 3keeB-4f48A:
undetectable		 3keeB-4f48A:
22.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gpg PROTEASE 1

(Achromobacter
lyticus) 		PF00089
(Trypsin) 		3 PHE A 114
TYR A  51
LEU A 209
 None
 0.75A 3keeB-4gpgA:
9.8		 3keeB-4gpgA:
22.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4h63 MEDIATOR OF RNA
POLYMERASE II
TRANSCRIPTION
SUBUNIT 11
MEDIATOR OF RNA
POLYMERASE II
TRANSCRIPTION
SUBUNIT 17

(Schizosaccharomyces
pombe) 		PF10156
(Med17)
no annotation 		3 PHE Q 397
TYR K  95
LEU Q 473
 None
 0.75A 3keeB-4h63Q:
undetectable		 3keeB-4h63Q:
16.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hbc ANTIGEN BINDING
FRAGMENT,
IMMUNOGLOBULIN IGG -
LIGHT CHAIN

(Oryctolagus
cuniculus) 		PF07654
(C1-set)
PF07686
(V-set) 		3 PHE L  71
TYR L  92
LEU L  47
 None
 0.70A 3keeB-4hbcL:
undetectable		 3keeB-4hbcL:
20.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hjj ANTI-IL12 ANTI-IL18
DFAB LIGHT CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		3 PHE L  71
TYR L  92
LEU L  47
 None
 0.80A 3keeB-4hjjL:
undetectable		 3keeB-4hjjL:
20.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kjz TRANSLATION
INITIATION FACTOR
IF-2

(Thermus
thermophilus) 		PF00009
(GTP_EFTU)
PF04760
(IF2_N)
PF11987
(IF-2) 		3 PHE A 430
TYR A 456
LEU A 449
 None
 0.75A 3keeB-4kjzA:
undetectable		 3keeB-4kjzA:
18.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4l0k DRAIII

(Deinococcus
radiophilus) 		no annotation 3 PHE A 196
TYR A 127
LEU A 162
 None
 0.70A 3keeB-4l0kA:
undetectable		 3keeB-4l0kA:
23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4m0h CONSERVED
HYPOTHETICAL
PROTEIN, PUTATIVE
ANTI-SIGMA FACTOR

(Parabacteroides
distasonis) 		PF04773
(FecR)
PF16344
(DUF4974) 		3 PHE A 175
TYR A 156
LEU A 197
 None
 0.73A 3keeB-4m0hA:
undetectable		 3keeB-4m0hA:
20.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mmh HEPARINASE III
PROTEIN

(Pedobacter
heparinus) 		PF07940
(Hepar_II_III)
PF16889
(Hepar_II_III_N) 		3 PHE A 435
TYR A 341
LEU A 415
 None
 0.68A 3keeB-4mmhA:
undetectable		 3keeB-4mmhA:
14.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4msx PRE-MRNA-SPLICING
FACTOR SAD1

(Saccharomyces
cerevisiae) 		PF00443
(UCH)
PF02148
(zf-UBP) 		3 PHE A  88
TYR A  31
LEU A  94
 None
 0.71A 3keeB-4msxA:
undetectable		 3keeB-4msxA:
16.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4nwk HCV NS3 1A PROTEASE

(Hepacivirus C) 		PF02907
(Peptidase_S29) 		3 PHE A  43
TYR A  56
LEU A 135
 2R8  A 301 (-4.6A)
None
2R8  A 301 (-4.4A)
 0.38A 3keeB-4nwkA:
30.5		 3keeB-4nwkA:
75.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4p79 CLAUDIN-15

(Mus musculus) 		PF00822
(PMP22_Claudin) 		3 PHE A  45
TYR A  50
LEU A 158
 None
OLC  A 201 (-4.3A)
None
 0.73A 3keeB-4p79A:
undetectable		 3keeB-4p79A:
26.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ux8 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE RECEPTOR RET

(Homo sapiens) 		PF00028
(Cadherin) 		3 PHE A 147
TYR A  36
LEU A 119
 None
 0.73A 3keeB-4ux8A:
undetectable		 3keeB-4ux8A:
15.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4x4y HUMAN VARIABLE LIGHT
CHAIN OF HERCEPTIN

(Homo sapiens) 		PF07686
(V-set) 		3 PHE B  71
TYR B  92
LEU B  47
 None
 0.63A 3keeB-4x4yB:
undetectable		 3keeB-4x4yB:
20.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4y9s EPOXIDE HYDROLASE

(Solanum
tuberosum) 		PF00561
(Abhydrolase_1) 		3 PHE A  29
TYR A  46
LEU A  36
 None
 0.75A 3keeB-4y9sA:
undetectable		 3keeB-4y9sA:
18.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yn2 FUSOLIN

(unidentified
entomopoxvirus) 		PF03067
(LPMO_10) 		3 PHE A 136
TYR A 223
LEU A 132
 None
 0.78A 3keeB-4yn2A:
undetectable		 3keeB-4yn2A:
21.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5c0n FAB CA33 LIGHT CHAIN

(Oryctolagus
cuniculus) 		no annotation 3 PHE L  71
TYR L  92
LEU L  47
 None
 0.73A 3keeB-5c0nL:
undetectable		 3keeB-5c0nL:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5dgk ACTIVE HELICASE

(Staphylococcus
aureus) 		PF06048
(DUF927) 		3 PHE A 541
TYR A 472
LEU A 517
 None
 0.79A 3keeB-5dgkA:
undetectable		 3keeB-5dgkA:
15.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5drz HIV ANTIBODY F240
LIGHT CHAIN

(Homo sapiens) 		no annotation 3 PHE L  71
TYR L  92
LEU L  47
 None
 0.71A 3keeB-5drzL:
undetectable		 3keeB-5drzL:
19.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5e59 FRNE PROTEIN

(Deinococcus
radiodurans) 		PF01323
(DSBA) 		3 PHE A 110
TYR A 178
LEU A  54
 None
 0.73A 3keeB-5e59A:
undetectable		 3keeB-5e59A:
21.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5eqq NS3 PROTEASE

(Hepacivirus C) 		PF02907
(Peptidase_S29) 		3 PHE A1043
TYR A1056
LEU A1135
 5RS  A1203 (-4.3A)
SO4  A1201 ( 4.5A)
5RS  A1203 (-4.2A)
 0.26A 3keeB-5eqqA:
30.8		 3keeB-5eqqA:
80.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5f72 SINGLE CHAIN FV FROM
A FAB

(Homo sapiens) 		no annotation 3 PHE T 212
TYR T 233
LEU T 188
 None
 0.75A 3keeB-5f72T:
undetectable		 3keeB-5f72T:
22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gvb WD REPEAT AND
HMG-BOX DNA-BINDING
PROTEIN 1

(Homo sapiens) 		PF12341
(Mcl1_mid) 		3 PHE A 584
TYR A 587
LEU A 540
 None
 0.76A 3keeB-5gvbA:
undetectable		 3keeB-5gvbA:
19.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gx8 EXTRACELLULAR
SOLUTE-BINDING
PROTEIN FAMILY 1

(Streptobacillus
moniliformis) 		PF13416
(SBP_bac_8) 		3 PHE A 404
TYR A 148
LEU A 401
 None
 0.66A 3keeB-5gx8A:
undetectable		 3keeB-5gx8A:
17.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5imy VAGINOLYSIN

(Gardnerella
vaginalis) 		PF01289
(Thiol_cytolysin)
PF17440
(Thiol_cytolys_C) 		3 PHE A 210
TYR A 195
LEU A 389
 None
 0.69A 3keeB-5imyA:
undetectable		 3keeB-5imyA:
16.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5j4r WELO5

(Hapalosiphon
welwitschii) 		no annotation 3 PHE A 252
TYR A 206
LEU A  15
 AKG  A 301 (-4.8A)
None
None
 0.76A 3keeB-5j4rA:
undetectable		 3keeB-5j4rA:
23.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kym 1-ACYL-SN-GLYCEROL-3
-PHOSPHATE
ACYLTRANSFERASE

(Thermotoga
maritima) 		PF01553
(Acyltransferase) 		3 PHE A  13
TYR A  20
LEU A   8
 None
DD9  A 304 ( 4.7A)
None
 0.71A 3keeB-5kymA:
undetectable		 3keeB-5kymA:
20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5loq PUTATIVE
HEME-DEPENDENT
PEROXIDASE LMO2113

(Listeria
monocytogenes) 		PF06778
(Chlor_dismutase) 		3 PHE A  17
TYR A  61
LEU A  99
 None
 0.72A 3keeB-5loqA:
undetectable		 3keeB-5loqA:
18.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5m1q PHAGE TERMINASE
LARGE SUBUNIT

(Thermus phage
G20c) 		PF17289
(Terminase_6C) 		3 PHE A 304
TYR A 301
LEU A 307
 None
 0.76A 3keeB-5m1qA:
undetectable		 3keeB-5m1qA:
22.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5m86 TA1207

(Thermoplasma
acidophilum) 		no annotation 3 PHE A  55
TYR A  88
LEU A  36
 GOL  A 403 (-3.4A)
None
None
 0.69A 3keeB-5m86A:
undetectable		 3keeB-5m86A:
19.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5mps PRE-MRNA-PROCESSING
FACTOR 17

(Saccharomyces
cerevisiae) 		PF00249
(Myb_DNA-binding) 		3 PHE o 302
TYR o 350
LEU o 299
 None
C  I  59 ( 4.7A)
None
 0.63A 3keeB-5mpso:
undetectable		 3keeB-5mpso:
16.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5mz6 SEPARASE

(Caenorhabditis
elegans) 		PF03568
(Peptidase_C50) 		3 PHE 1 249
TYR 1 646
LEU 1 692
 None
 0.77A 3keeB-5mz61:
undetectable		 3keeB-5mz61:
9.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5nbi DESIGN OF ANTIBODIES

(Escherichia
coli) 		PF07654
(C1-set)
PF07686
(V-set) 		3 PHE L  75
TYR L  96
LEU L  51
 None
 0.79A 3keeB-5nbiL:
undetectable		 3keeB-5nbiL:
20.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ogs WD REPEAT AND
HMG-BOX DNA-BINDING
PROTEIN 1

(Homo sapiens) 		no annotation 3 PHE A 584
TYR A 587
LEU A 540
 None
 0.75A 3keeB-5ogsA:
undetectable		 3keeB-5ogsA:
18.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5t2k PUTATIVE
HEME-DEPENDENT
PEROXIDASE
GT50_08830

(Geobacillus
stearothermophilus) 		PF06778
(Chlor_dismutase) 		3 PHE A  17
TYR A  61
LEU A  99
 None
 0.68A 3keeB-5t2kA:
undetectable		 3keeB-5t2kA:
23.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5t4y SUSC HOMOLOG

(Bacteroides
thetaiotaomicron) 		no annotation 3 PHE D 592
TYR D 589
LEU D 573
 None
 0.69A 3keeB-5t4yD:
undetectable		 3keeB-5t4yD:
10.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5thh TYROSINE--TRNA
LIGASE, CYTOPLASMIC

(Homo sapiens) 		PF00579
(tRNA-synt_1b) 		3 PHE A  73
TYR A  96
LEU A  76
 None
 0.71A 3keeB-5thhA:
undetectable		 3keeB-5thhA:
18.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ue8 PROTEIN UNC-13
HOMOLOG A

(Rattus
norvegicus) 		PF00130
(C1_1)
PF00168
(C2)
PF06292
(DUF1041)
PF10540
(Membr_traf_MHD) 		3 PHE A1025
TYR A1110
LEU A1017
 None
 0.78A 3keeB-5ue8A:
undetectable		 3keeB-5ue8A:
11.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wdx JFH-1 NS3

(Hepacivirus C) 		no annotation 3 PHE A  43
TYR A  56
LEU A 135
 None
 0.28A 3keeB-5wdxA:
25.3		 3keeB-5wdxA:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xgj PHOSPHATIDYLINOSITOL
4,5-BISPHOSPHATE
3-KINASE CATALYTIC
SUBUNIT ALPHA
ISOFORM

(Homo sapiens) 		no annotation 3 PHE A 550
TYR A 557
LEU A 570
 None
 0.78A 3keeB-5xgjA:
undetectable		 3keeB-5xgjA:
16.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xhq APOLIPOPROTEIN
N-ACYLTRANSFERASE

(Escherichia
coli) 		PF00795
(CN_hydrolase) 		3 PHE A 400
TYR A 406
LEU A 392
 None
 0.78A 3keeB-5xhqA:
undetectable		 3keeB-5xhqA:
17.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xs2 CYCLIN-C

(Homo sapiens) 		PF00134
(Cyclin_N)
PF16899
(Cyclin_C_2) 		3 PHE B 195
TYR B 192
LEU B 160
 None
 0.74A 3keeB-5xs2B:
undetectable		 3keeB-5xs2B:
20.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5y3r DNA-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT

(Homo sapiens) 		PF00454
(PI3_PI4_kinase)
PF02259
(FAT)
PF02260
(FATC)
PF08163
(NUC194) 		3 PHE C1978
TYR C2030
LEU C1934
 None
 0.66A 3keeB-5y3rC:
undetectable		 3keeB-5y3rC:
3.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5yhi PROTEIN YIIM

(Escherichia
coli) 		no annotation 3 PHE A  84
TYR A  67
LEU A  88
 None
 0.73A 3keeB-5yhiA:
undetectable		 3keeB-5yhiA:
19.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6c6l V-TYPE PROTON ATPASE
SUBUNIT A, VACUOLAR
ISOFORM

(Saccharomyces
cerevisiae) 		no annotation 3 PHE A 545
TYR A 552
LEU A 736
 None
 0.77A 3keeB-6c6lA:
undetectable		 3keeB-6c6lA:
15.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cet GATOR COMPLEX
PROTEIN DEPDC5

(Homo sapiens) 		no annotation 3 PHE D 278
TYR D 191
LEU D 270
 None
 0.76A 3keeB-6cetD:
undetectable		 3keeB-6cetD:
16.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6eqc SCFV OF 9C12
ANTIBODY

(Mus musculus) 		no annotation 3 PHE D  78
TYR D  99
LEU D  54
 None
 0.78A 3keeB-6eqcD:
undetectable		 3keeB-6eqcD:
19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6f0k ACTD

(Rhodothermus
marinus) 		no annotation 3 PHE D 110
TYR D 101
LEU D 113
 None
HEC  A 301 (-4.3A)
None
 0.67A 3keeB-6f0kD:
undetectable		 3keeB-6f0kD:
16.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6f42 DNA-DIRECTED RNA
POLYMERASE III
SUBUNIT RPC1
DNA-DIRECTED RNA
POLYMERASE III
SUBUNIT RPC2

(Saccharomyces
cerevisiae) 		no annotation 3 PHE B 678
TYR B 975
LEU A 856
 None
 0.72A 3keeB-6f42B:
undetectable		 3keeB-6f42B:
19.64